Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD

NCT02884908 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Maryland, Baltimore

Collaborators